Genelux (GNLX) Operating Expenses (2022 - 2026)

Genelux's (GNLX) quarterly Operating Expenses came in at $9.2 million in Q1 2026, up 17.34% year-on-year from $7.8 million in Q1 2025, and down 2.64% quarter-over-quarter from $9.4 million in Q4 2025.

Genelux (GNLX) Operating Expenses (2022 - 2026) Analysis & Trends

Genelux's Operating Expenses history runs 5 years deep, the most recent figure standing at $9.2 million for Q1 2026.

  • On a quarterly basis, Operating Expenses rose 17.34% year-over-year to $9.2 million in Q1 2026; TTM through Mar 2026 was $34.6 million, a 10.13% increase from a year earlier, with the FY2025 full-year figure at $33.2 million, up 4.79% from the prior year.
  • Operating Expenses eased to $9.2 million in Q1 2026 per GNLX's latest filing, from $9.4 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $9.7 million in Q4 2024 and bottomed at $3.2 million in Q4 2022.
  • The 5-year median for Operating Expenses is $7.0 million (2023), against an average of $7.1 million.
  • Across the five-year window, Operating Expenses surged 121.41% in 2023 and slipped 3.78% in 2025, its largest moves.
  • Year by year, Operating Expenses stood at $3.2 million in 2022, then surged by 121.41% to $7.0 million in 2023, then surged by 39.24% to $9.7 million in 2024, then dropped by 3.36% to $9.4 million in 2025, then decreased by 2.64% to $9.2 million in 2026.
  • Per Business Quant, the three latest GNLX Operating Expenses figures stand at $9.2 million (Q1 2026), $9.4 million (Q4 2025), and $8.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Oculis Holding AG 66,741.39 Bn 66,741.11 Bn - -28.01 Mn
2 Nanobiotix 1,935.05 Bn 1,934.98 Bn - -
3 Akari Therapeutics 1,045.06 Bn 1,045.06 Bn - 15.76 Mn
4 BeOne Medicines 468.98 Bn 464.19 Bn 1.35 Bn 1.10 Bn
5 Vertex Pharmaceuticals 123.24 Bn 115.99 Bn 2.59 Bn 1.85 Bn
6 Regeneron Pharmaceuticals 70.45 Bn 61.70 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 63.04 Bn 63.04 Bn - 32.68 Mn
8 Argenx Se 55.79 Bn 50.60 Bn 1.41 Bn 2.89 Bn
9 Alnylam Pharmaceuticals 37.79 Bn 34.78 Bn 959.66 Mn 898.54 Mn
10 Genelux 129.36 Mn 129.36 Mn - 9.17 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.17 Mn
Dec 31, 2025 9.42 Mn
Sep 30, 2025 8.19 Mn
Jun 30, 2025 7.79 Mn
Mar 31, 2025 7.82 Mn
Dec 31, 2024 9.75 Mn
Sep 30, 2024 6.94 Mn
Jun 30, 2024 6.89 Mn
Mar 31, 2024 8.12 Mn
Dec 31, 2023 7.00 Mn
Sep 30, 2023 5.31 Mn
Jun 30, 2023 5.40 Mn
Mar 31, 2023 6.63 Mn
Dec 31, 2022 3.16 Mn
Sep 30, 2022 4.66 Mn